| Dr Philip Kurt Robb Jr, MD | |
|
4301 W Markham St, 543, Little Rock, AR 72205-7101 | |
| (678) 488-3105 | |
| Not Available |
| Full Name | Dr Philip Kurt Robb Jr |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Otolaryngology/facial Plastic Surgery |
| Location | 4301 W Markham St, Little Rock, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639460777 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 74999 (Georgia) | Primary |
| Entity Name | Philip K. Robb, M.d., Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386912475 PECOS PAC ID: 5991970592 Enrollment ID: O20111209000396 |
News Archive
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, launched its Oncology Care Analysis (OCA) program. This patient-focused, integrated program uses a first-of-its-kind database that combines clinical and claims data to gauge the quality of cancer patient care based on approved treatment guidelines from the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers.
Mayo Clinic researchers will receive more than $3 million in a four-year grant from the National Human Genome Research Institute to translate recent genomic discoveries into tools for individualized medicine. Recent advances in the genetics of heart and blood vessel diseases will be integrated into electronic medical records so doctors can more accurately determine patients' risk of heart attacks, blood vessel diseases and adverse reactions to heart medications.
Tikcro Technologies Ltd. today announced that BioCancell Therapeutics, Inc., concluded the first 18 patient group treated pursuant to a Phase IIb clinical trial of the drug candidate BC-819 for use in superficial bladder cancer. These patients had not responded to conventional treatment.
A new in vitro (test tube) study, "Dietary functional benefits of Bartlett and Starkrimson pears for potential management of hyperglycemia, hypertension and ulcer bacteria Helicobacter pylori while supporting beneficial probiotic bacterial response," was published in the March issue of Food Research International.
Governor Tom Wolf and Insurance Commissioner Teresa Miller today continued the Wolf Administration's consumer outreach and education efforts with the release of a video that offers consumers tips on how to use their health insurance.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Philip Kurt Robb Jr, MD 3400 Old Milton Pkwy, Bldg C Suite 575, Alpharetta, GA 30005 Ph: (770) 410-0202 | Dr Philip Kurt Robb Jr, MD 4301 W Markham St, 543, Little Rock, AR 72205-7101 Ph: (678) 488-3105 |
News Archive
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, launched its Oncology Care Analysis (OCA) program. This patient-focused, integrated program uses a first-of-its-kind database that combines clinical and claims data to gauge the quality of cancer patient care based on approved treatment guidelines from the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers.
Mayo Clinic researchers will receive more than $3 million in a four-year grant from the National Human Genome Research Institute to translate recent genomic discoveries into tools for individualized medicine. Recent advances in the genetics of heart and blood vessel diseases will be integrated into electronic medical records so doctors can more accurately determine patients' risk of heart attacks, blood vessel diseases and adverse reactions to heart medications.
Tikcro Technologies Ltd. today announced that BioCancell Therapeutics, Inc., concluded the first 18 patient group treated pursuant to a Phase IIb clinical trial of the drug candidate BC-819 for use in superficial bladder cancer. These patients had not responded to conventional treatment.
A new in vitro (test tube) study, "Dietary functional benefits of Bartlett and Starkrimson pears for potential management of hyperglycemia, hypertension and ulcer bacteria Helicobacter pylori while supporting beneficial probiotic bacterial response," was published in the March issue of Food Research International.
Governor Tom Wolf and Insurance Commissioner Teresa Miller today continued the Wolf Administration's consumer outreach and education efforts with the release of a video that offers consumers tips on how to use their health insurance.
› Verified 5 days ago
Dr. Suzanne Elizabeth Smart, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 753, Little Rock, AR 72205 Phone: 501-686-8000 | |
Dr. John R. E. Dickins, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10201 Kanis Rd, Little Rock, AR 72205 Phone: 501-227-5050 Fax: 501-227-5151 | |
Ozlem Tulunay Ugur, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Slot #543, Little Rock, AR 72205 Phone: 501-686-5140 Fax: 501-686-8029 | |
Dr. Aaron Damian Trinidade, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Emre Vural, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Dr. James Floyd Kyser, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2211 N Spruce St, Little Rock, AR 72207 Phone: 501-664-4455 Fax: 501-664-4454 | |
Dr. Tristan John Allsopp, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St, Little Rock, AR 72205 Phone: 501-603-1501 |